Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
MCL1, a pro-survival BCL-2 related protein with rapid turnover rate, is often dysregulated in cancers. Here, the authors show that MCL1’s stability is regulated by deubiquitinase USP13, and its inhibition sensitises tumor cells to BH3 mimetic inhibitors.
Guardado en:
Autores principales: | Shengzhe Zhang, Meiying Zhang, Ying Jing, Xia Yin, Pengfei Ma, Zhenfeng Zhang, Xiaojie Wang, Wen Di, Guanglei Zhuang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/09dfe8475f7d4341b4c32047ce2e5387 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BH3-mimetics: recent developments in cancer therapy
por: Paul A. Townsend, et al.
Publicado: (2021) -
The deubiquitinase USP38 affects cellular functions through interacting with LSD1
por: Liu,Wenbin, et al.
Publicado: (2018) -
Stapled BH3 peptides against MCL-1: mechanism and design using atomistic simulations.
por: Thomas L Joseph, et al.
Publicado: (2012) -
USP52 acts as a deubiquitinase and promotes histone chaperone ASF1A stabilization
por: Shangda Yang, et al.
Publicado: (2018) -
EGF receptor kinase suppresses ciliogenesis through activation of USP8 deubiquitinase
por: Kousuke Kasahara, et al.
Publicado: (2018)